XML 98 R27.htm IDEA: XBRL DOCUMENT v3.3.0.814
Consolidating Guarantor Financial Information
9 Months Ended
Sep. 30, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Consolidating Guarantor Financial Information
Consolidating Guarantor Financial Information:
The 2014 Senior Notes issued by Albemarle Corporation (the “Issuer”) were fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Rockwood Holdings, Inc. (“RHI”) and Rockwood Specialties Group, Inc. (“RSGI”) (the “Guarantor Subsidiaries”). The Guarantor Subsidiaries are 100% owned subsidiaries of the Issuer. The guarantees were general senior unsecured obligations of the Guarantor Subsidiaries and ranked equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantor Subsidiaries that are not, by their terms, otherwise expressly subordinated. The note guarantees were released when the 4.625% senior notes were repaid on October 15, 2015.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash among the Issuer, Guarantor Subsidiaries and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the periods included herein present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantor Subsidiaries to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Issuer, Guarantor Subsidiaries, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the condensed consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described herein and in our Annual Report on Form 10-K for the year ended December 31, 2014.
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
357,269

 
$

 
$
734,109

 
$
(186,285
)
 
$
905,093

Cost of goods sold
252,634

 

 
526,534

 
(186,285
)
 
592,883

Gross profit
104,635

 

 
207,575

 

 
312,210

Selling, general and administrative expenses
40,721

 

 
96,894

 

 
137,615

Research and development expenses
12,874

 

 
12,421

 

 
25,295

Restructuring and other, net
(61
)
 

 
(6,743
)
 

 
(6,804
)
Acquisition and integration related costs
28,479

 

 
14,319

 

 
42,798

Intercompany service fee
5,914

 

 
(5,914
)
 

 

Operating profit
16,708

 

 
96,598

 

 
113,306

Interest and financing expenses
(21,758
)
 
(12,546
)
 
2,246

 

 
(32,058
)
Intergroup interest and financing expenses
(8,697
)
 
15,147

 
(6,450
)
 

 

Other income (expenses), net
(2,320
)
 
4,376

 
(1,590
)
 

 
466

Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments
(16,067
)
 
6,977

 
90,804

 

 
81,714

Income tax expense (benefit)
(9,491
)
 
4,020

 
22,363

 

 
16,892

Income (loss) from continuing operations before equity in net income of unconsolidated investments
(6,576
)
 
2,957

 
68,441

 

 
64,822

Equity in net income of unconsolidated investments (net of tax)
1,315

 

 
4,735

 

 
6,050

Net income (loss) from continuing operations
(5,261
)
 
2,957

 
73,176

 

 
70,872

Income (loss) from discontinued operations (net of tax)

 

 

 

 

Equity in undistributed earnings of subsidiaries
70,653

 
33,465

 
18,211

 
(122,329
)
 

Net income
65,392

 
36,422

 
91,387

 
(122,329
)
 
70,872

Net income attributable to noncontrolling interests

 

 
(5,480
)
 

 
(5,480
)
Net income attributable to Albemarle Corporation
$
65,392

 
$
36,422

 
$
85,907

 
$
(122,329
)
 
$
65,392



Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended September 30, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
65,392

 
$
36,422

 
$
91,387

 
$
(122,329
)
 
$
70,872

Total other comprehensive loss, net of tax
(70,007
)
 
(103,764
)
 
(118,228
)
 
221,595

 
(70,404
)
Comprehensive income (loss)
(4,615
)
 
(67,342
)
 
(26,841
)
 
99,266

 
468

Comprehensive income attributable to noncontrolling interests

 

 
(5,083
)
 

 
(5,083
)
Comprehensive loss attributable to Albemarle Corporation
$
(4,615
)
 
$
(67,342
)
 
$
(31,924
)
 
$
99,266

 
$
(4,615
)

Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,109,661

 
$

 
$
2,153,749

 
$
(542,428
)
 
$
2,720,982

Cost of goods sold
767,626

 

 
1,622,121

 
(540,007
)
 
1,849,740

Gross profit
342,035

 

 
531,628

 
(2,421
)
 
871,242

Selling, general and administrative expenses
127,591

 
46

 
293,455

 

 
421,092

Research and development expenses
39,143

 

 
37,980

 

 
77,123

Restructuring and other, net
(61
)
 

 
(6,743
)
 

 
(6,804
)
Acquisition and integration related costs
86,648

 

 
39,839

 

 
126,487

Intercompany service fee
17,557

 

 
(17,557
)
 

 

Operating profit (loss)
71,157

 
(46
)
 
184,654

 
(2,421
)
 
253,344

Interest and financing expenses
(70,279
)
 
(36,257
)
 
5,550

 

 
(100,986
)
Intergroup interest and financing expenses
(23,143
)
 
40,862

 
(17,719
)
 

 

Other income (expenses), net
6,624

 
(26,844
)
 
71,184

 

 
50,964

Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments
(15,641
)
 
(22,285
)
 
243,669

 
(2,421
)
 
203,322

Income tax expense (benefit)
(1,148
)
 
6,992

 
43,219

 
(892
)
 
48,171

Income (loss) from continuing operations before equity in net income of unconsolidated investments
(14,493
)
 
(29,277
)
 
200,450

 
(1,529
)
 
155,151

Equity in net income of unconsolidated investments (net of tax)
5,072

 

 
17,164

 

 
22,236

Net income (loss) from continuing operations
(9,421
)
 
(29,277
)
 
217,614

 
(1,529
)
 
177,387

Income (loss) from discontinued operations (net of tax)

 

 

 

 

Equity in undistributed earnings of subsidiaries
170,075

 
117,147

 
43,935

 
(331,157
)
 

Net income
160,654

 
87,870

 
261,549

 
(332,686
)
 
177,387

Net income attributable to noncontrolling interests

 

 
(16,733
)
 

 
(16,733
)
Net income attributable to Albemarle Corporation
$
160,654

 
$
87,870

 
$
244,816

 
$
(332,686
)
 
$
160,654



Condensed Consolidating Statement of Comprehensive Loss
Nine Months Ended September 30, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
160,654

 
$
87,870

 
$
261,549

 
$
(332,686
)
 
$
177,387

Total other comprehensive loss, net of tax
(324,000
)
 
(538,439
)
 
(662,793
)
 
1,200,684

 
(324,548
)
Comprehensive loss
(163,346
)
 
(450,569
)
 
(401,244
)
 
867,998

 
(147,161
)
Comprehensive income attributable to noncontrolling interests

 

 
(16,185
)
 

 
(16,185
)
Comprehensive loss attributable to Albemarle Corporation
$
(163,346
)
 
$
(450,569
)
 
$
(417,429
)
 
$
867,998

 
$
(163,346
)
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
403,072

 
$

 
$
424,423

 
$
(185,077
)
 
$
642,418

Cost of goods sold
275,187

 

 
342,149

 
(180,364
)
 
436,972

Gross profit
127,885

 

 
82,274

 
(4,713
)
 
205,446

Selling, general and administrative expenses
42,836

 

 
23,176

 

 
66,012

Research and development expenses
13,959

 

 
8,448

 

 
22,407

Restructuring and other, net
(2,197
)
 

 
2,490

 

 
293

Acquisition and integration related costs
10,261

 

 

 

 
10,261

Intercompany service fee
11,664

 

 
(11,664
)
 

 

Operating profit
51,362

 

 
59,824

 
(4,713
)
 
106,473

Interest and financing expenses
(8,791
)
 

 
42

 

 
(8,749
)
Other income (expenses), net
(3,151
)
 

 
(3,467
)
 

 
(6,618
)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments
39,420

 

 
56,399

 
(4,713
)
 
91,106

Income tax expense
7,636

 

 
5,823

 
(1,722
)
 
11,737

Income from continuing operations before equity in net income of unconsolidated investments
31,784

 

 
50,576

 
(2,991
)
 
79,369

Equity in net income of unconsolidated investments (net of tax)
997

 

 
7,653

 

 
8,650

Net income from continuing operations
32,781

 

 
58,229

 
(2,991
)
 
88,019

Loss from discontinued operations (net of tax)
608

 

 
(7,287
)
 

 
(6,679
)
Equity in undistributed earnings of subsidiaries
39,405

 

 

 
(39,405
)
 

Net income
72,794

 

 
50,942

 
(42,396
)
 
81,340

Net income attributable to noncontrolling interests

 

 
(8,546
)
 

 
(8,546
)
Net income attributable to Albemarle Corporation
$
72,794

 
$

 
$
42,396

 
$
(42,396
)
 
$
72,794



Condensed Consolidating Statement of Comprehensive Loss
Three Months Ended September 30, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
72,794

 
$

 
$
50,942

 
$
(42,396
)
 
$
81,340

Total other comprehensive loss, net of tax
(101,295
)
 

 
(100,260
)
 
100,135

 
(101,420
)
Comprehensive loss
(28,501
)
 

 
(49,318
)
 
57,739

 
(20,080
)
Comprehensive income attributable to noncontrolling interests

 

 
(8,421
)
 

 
(8,421
)
Comprehensive loss attributable to Albemarle Corporation
$
(28,501
)
 
$

 
$
(57,739
)
 
$
57,739

 
$
(28,501
)
Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,198,531

 
$

 
$
1,169,507

 
$
(521,056
)
 
$
1,846,982

Cost of goods sold
804,764

 

 
953,726

 
(519,916
)
 
1,238,574

Gross profit
393,767

 

 
215,781

 
(1,140
)
 
608,408

Selling, general and administrative expenses
141,411

 

 
69,716

 

 
211,127

Research and development expenses
41,772

 

 
25,144

 

 
66,916

Restructuring and other, net
8,049

 

 
12,576

 

 
20,625

Acquisition and integration related costs
15,104

 

 

 

 
15,104

Intercompany service fee
23,672

 

 
(23,672
)
 

 

Operating profit
163,759

 

 
132,017

 
(1,140
)
 
294,636

Interest and financing expenses
(26,320
)
 

 
65

 

 
(26,255
)
Intergroup interest and financing expenses
6,010

 

 
(6,010
)
 

 

Other income (expenses), net
(2,161
)
 

 
(4,293
)
 

 
(6,454
)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments
141,288

 

 
121,779

 
(1,140
)
 
261,927

Income tax expense
40,156

 

 
6,960

 
(416
)
 
46,700

Income from continuing operations before equity in net income of unconsolidated investments
101,132

 

 
114,819

 
(724
)
 
215,227

Equity in net income of unconsolidated investments (net of tax)
4,926

 

 
23,274

 

 
28,200

Net income from continuing operations
106,058

 

 
138,093

 
(724
)
 
243,427

Loss from discontinued operations (net of tax)
(20,549
)
 

 
(47,924
)
 

 
(68,473
)
Equity in undistributed earnings of subsidiaries
66,315

 

 

 
(66,315
)
 

Net income
151,824

 

 
90,169

 
(67,039
)
 
174,954

Net income attributable to noncontrolling interests

 

 
(23,130
)
 

 
(23,130
)
Net income attributable to Albemarle Corporation
$
151,824

 
$

 
$
67,039

 
$
(67,039
)
 
$
151,824



Condensed Consolidating Statement of Comprehensive Income (Loss)
Nine Months Ended September 30, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
151,824

 
$

 
$
90,169

 
$
(67,039
)
 
$
174,954

Total other comprehensive loss, net of tax
(117,896
)
 

 
(106,319
)
 
105,916

 
(118,299
)
Comprehensive income (loss)
33,928

 

 
(16,150
)
 
38,877

 
56,655

Comprehensive income attributable to noncontrolling interests

 

 
(22,727
)
 

 
(22,727
)
Comprehensive income (loss) attributable to Albemarle Corporation
$
33,928

 
$

 
$
(38,877
)
 
$
38,877

 
$
33,928


Condensed Consolidating Balance Sheet
September 30, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
4,416

 
$
1,103

 
$
228,971

 
$

 
$
234,490

Trade accounts receivable, less allowance for doubtful accounts
92,694

 

 
525,607

 

 
618,301

Other accounts receivable
15,031

 
23,915

 
37,325

 

 
76,271

Intergroup receivable
191,295

 
12,455

 
352,388

 
(556,138
)
 

Inventories
207,445

 

 
435,211

 
(13,263
)
 
629,393

Other current assets
51,717

 

 
121,821

 
(11,078
)
 
162,460

Total current assets
562,598

 
37,473

 
1,701,323

 
(580,479
)
 
1,720,915

Property, plant and equipment, at cost
1,765,817

 

 
2,331,104

 

 
4,096,921

Less accumulated depreciation and amortization
1,087,130

 

 
408,939

 

 
1,496,069

Net property, plant and equipment
678,687

 

 
1,922,165

 

 
2,600,852

Investments
74,429

 
4,891

 
374,549

 

 
453,869

Investment in subsidiaries
7,073,096

 
11,164,495

 
6,380,635

 
(24,618,226
)
 

Other assets
30,572

 
3,250

 
157,527

 

 
191,349

Goodwill
49,212

 

 
2,761,874

 

 
2,811,086

Other intangibles, net of amortization
19,265

 

 
1,877,728

 

 
1,896,993

Intergroup receivable

 
3,307,998

 
1,847,122

 
(5,155,120
)
 

Total assets
$
8,487,859

 
$
14,518,107

 
$
17,022,923

 
$
(30,353,825
)
 
$
9,675,064

Liabilities and Equity
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
121,835

 
$

 
$
249,814

 
$

 
$
371,649

Intergroup payable
365,452

 
102,086

 
88,600

 
(556,138
)
 

Accrued expenses
189,637

 
137,161

 
240,134

 

 
566,932

Current portion of long-term debt
272,994

 

 
11,374

 

 
284,368

Dividends payable
32,295

 

 

 

 
32,295

Income taxes payable

 
11,076

 
68,196

 
(11,968
)
 
67,304

Total current liabilities
982,213

 
250,323

 
658,118

 
(568,106
)
 
1,322,548

Long-term debt
2,230,720

 
1,287,643

 
40,601

 

 
3,558,964

Postretirement benefits
55,401

 

 

 

 
55,401

Pension benefits
120,593

 

 
330,463

 

 
451,056

Intergroup payable
1,810,546

 
1,019,458

 
2,325,116

 
(5,155,120
)
 

Other noncurrent liabilities
53,933

 
57,995

 
138,809

 

 
250,737

Deferred income taxes
89,964

 
3,031

 
668,849

 

 
761,844

Commitments and contingencies


 


 


 


 


Equity:
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
Common stock
1,122

 

 
6,808

 
(6,808
)
 
1,122

Additional paid-in capital
2,056,082

 
12,350,226

 
12,159,684

 
(24,509,910
)
 
2,056,082

Accumulated other comprehensive loss
(386,413
)
 
(538,439
)
 
(713,001
)
 
1,251,440

 
(386,413
)
Retained earnings
1,473,698

 
87,870

 
1,277,451

 
(1,365,321
)
 
1,473,698

Total Albemarle Corporation shareholders’ equity
3,144,489

 
11,899,657

 
12,730,942

 
(24,630,599
)
 
3,144,489

Noncontrolling interests

 

 
130,025

 

 
130,025

Total equity
3,144,489

 
11,899,657

 
12,860,967

 
(24,630,599
)
 
3,274,514

Total liabilities and equity
$
8,487,859

 
$
14,518,107

 
$
17,022,923

 
$
(30,353,825
)
 
$
9,675,064


Condensed Consolidating Balance Sheet
December 31, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1,930,802

 
$

 
$
558,966

 
$

 
$
2,489,768

Trade accounts receivable, less allowance for doubtful accounts
91,849

 

 
293,363

 

 
385,212

Other accounts receivable
19,033

 

 
30,390

 

 
49,423

Intergroup receivable
74,102

 

 
18,097

 
(92,199
)
 

Inventories
201,006

 

 
171,543

 
(14,188
)
 
358,361

Other current assets
45,901

 

 
25,111

 
(4,926
)
 
66,086

Total current assets
2,362,693

 

 
1,097,470

 
(111,313
)
 
3,348,850

Property, plant and equipment, at cost
1,726,690

 

 
893,980

 

 
2,620,670

Less accumulated depreciation and amortization
1,047,372

 

 
341,430

 

 
1,388,802

Net property, plant and equipment
679,318

 

 
552,550

 

 
1,231,868

Investments
73,500

 

 
120,542

 

 
194,042

Investment in subsidiaries
1,551,071

 

 

 
(1,551,071
)
 

Other assets
35,837

 

 
125,119

 

 
160,956

Goodwill
49,212

 

 
194,050

 

 
243,262

Other intangibles, net of amortization
20,834

 

 
23,291

 

 
44,125

Total assets
$
4,772,465

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103

Liabilities and Equity
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Accounts payable
$
122,479

 
$

 
$
109,226

 
$

 
$
231,705

Intergroup payable
18,097

 

 
74,102

 
(92,199
)
 

Accrued expenses
84,619

 

 
81,555

 

 
166,174

Current portion of long-term debt
692,280

 

 
18,816

 

 
711,096

Dividends payable
21,458

 

 

 

 
21,458

Income taxes payable
1,396

 

 
7,944

 
113

 
9,453

Total current liabilities
940,329

 

 
291,643

 
(92,086
)
 
1,139,886

Long-term debt
2,214,755

 

 
8,280

 

 
2,223,035

Postretirement benefits
56,424

 

 

 

 
56,424

Pension benefits
128,238

 

 
42,296

 

 
170,534

Other noncurrent liabilities
51,936

 

 
35,769

 

 
87,705

Deferred income taxes
21,318

 

 
35,566

 

 
56,884

Commitments and contingencies


 


 


 


 


Equity:
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
Common stock
780

 

 
6,808

 
(6,808
)
 
780

Additional paid-in capital
10,447

 

 
553,172

 
(553,172
)
 
10,447

Accumulated other comprehensive loss
(62,413
)
 

 
(51,073
)
 
51,073

 
(62,413
)
Retained earnings
1,410,651

 

 
1,061,391

 
(1,061,391
)
 
1,410,651

Total Albemarle Corporation shareholders’ equity
1,359,465

 

 
1,570,298

 
(1,570,298
)
 
1,359,465

Noncontrolling interests

 

 
129,170

 

 
129,170

Total equity
1,359,465

 

 
1,699,468

 
(1,570,298
)
 
1,488,635

Total liabilities and equity
$
4,772,465

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103


Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2015
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
1,930,802

 
$

 
$
558,966

 
$

 
$
2,489,768

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
369,333

 
(48,867
)
 
19,839

 
(23,402
)
 
316,903

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Acquisition of Rockwood, net of cash acquired
(3,597,083
)
 
159,409

 
1,386,029

 

 
(2,051,645
)
Other acquisitions, net of cash acquired

 

 
(48,845
)
 

 
(48,845
)
Capital expenditures
(51,900
)
 

 
(112,668
)
 

 
(164,568
)
Decrease in restricted cash

 

 
57,550

 

 
57,550

Cash proceeds from divestitures, net

 

 
6,133

 

 
6,133

Return of capital

 

 
98,000

 

 
98,000

Sales of (investments in) marketable securities, net
1,271

 

 
(6
)
 

 
1,265

Repayments from (long-term advances to) joint ventures
2,156

 

 

 

 
2,156

Proceeds from intercompany investing related activity

 
1,213,717

 
82

 
(1,213,799
)
 

Intercompany investing related payments

 
(1,324,960
)
 
(1,341,728
)
 
2,666,688

 

Net cash (used in) provided by investing activities
(3,645,556
)
 
48,166

 
44,547

 
1,452,889

 
(2,099,954
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(1,325,104
)
 

 
(7,189
)
 

 
(1,332,293
)
Proceeds from borrowings of long-term debt
1,000,000

 

 

 

 
1,000,000

Repayments of other borrowings, net
(16,018
)
 

 
(836
)
 

 
(16,854
)
Dividends paid to shareholders
(86,770
)
 

 

 

 
(86,770
)
Dividends paid to noncontrolling interests

 

 
(23,195
)
 

 
(23,195
)
Intercompany dividends paid

 

 
(23,402
)
 
23,402

 

Proceeds from exercise of stock options
342

 

 

 

 
342

Excess tax benefits realized from stock-based compensation arrangements
59

 

 

 

 
59

Withholding taxes paid on stock-based compensation award distributions
(1,218
)
 

 

 

 
(1,218
)
Debt financing costs
(4,186
)
 

 

 

 
(4,186
)
Other

 

 
(3,882
)
 

 
(3,882
)
Proceeds from intercompany financing related activity
1,845,770

 

 
820,918

 
(2,666,688
)
 

Intercompany financing related payments
(62,039
)
 
(82
)
 
(1,151,678
)
 
1,213,799

 

Net cash provided by (used in) financing activities
1,350,836

 
(82
)
 
(389,264
)
 
(1,429,487
)
 
(467,997
)
Net effect of foreign exchange on cash and cash equivalents
(999
)
 
1,886

 
(5,117
)
 

 
(4,230
)
(Decrease) increase in cash and cash equivalents
(1,926,386
)
 
1,103

 
(329,995
)
 

 
(2,255,278
)
Cash and cash equivalents at end of period
$
4,416

 
$
1,103

 
$
228,971

 
$

 
$
234,490


Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2014
(In Thousands)
Issuer
 
Guarantor Subsidiaries
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
88,476

 
$

 
$
388,763

 
$

 
$
477,239

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
203,834

 

 
232,718

 
(6,010
)
 
430,542

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
Capital expenditures
(57,124
)
 

 
(19,558
)
 

 
(76,682
)
Cash proceeds from divestitures, net
97,523

 

 
7,195

 

 
104,718

Sales of (investments in) marketable securities, net
962

 

 
(19
)
 

 
943

Repayments from (long-term advances to) joint ventures

 

 
(7,499
)
 

 
(7,499
)
Net cash provided by (used in) investing activities
41,361

 

 
(19,881
)
 

 
21,480

Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(108
)
 

 
(2,915
)
 

 
(3,023
)
Repayments of other borrowings, net
(7,124
)
 

 
(16,430
)
 

 
(23,554
)
Dividends paid to shareholders
(62,827
)
 

 

 

 
(62,827
)
Dividends paid to noncontrolling interests

 

 
(7,612
)
 

 
(7,612
)
Intercompany dividends paid

 

 
(6,010
)
 
6,010

 

Repurchases of common stock
(150,000
)
 

 

 

 
(150,000
)
Proceeds from exercise of stock options
2,713

 

 

 

 
2,713

Excess tax benefits realized from stock-based compensation arrangements
836

 

 

 

 
836

Withholding taxes paid on stock-based compensation award distributions
(3,208
)
 

 

 

 
(3,208
)
Debt financing costs
(3,074
)
 

 

 

 
(3,074
)
Net cash used in financing activities
(222,792
)
 

 
(32,967
)
 
6,010

 
(249,749
)
Net effect of foreign exchange on cash and cash equivalents

 

 
(26,392
)
 

 
(26,392
)
Increase in cash and cash equivalents
22,403

 

 
153,478

 

 
175,881

Cash and cash equivalents at end of period
$
110,879

 
$

 
$
542,241

 
$

 
$
653,120


The 4.625% senior notes issued in September 2012 by RSGI (the “Issuer”) were fully and unconditionally guaranteed, jointly and severally, on an unsecured and unsubordinated basis by Albemarle Corporation (the “Parent Company Guarantor”) and RHI (the “Guarantor Subsidiary,” and together with the Parent Company Guarantor, the “Guarantors”). The guarantees are general senior unsecured obligations of the Guarantors and ranked equally in right of payment with all existing and future senior unsecured indebtedness and other obligations of the Guarantors that were not, by their terms, otherwise expressly subordinated. The note guarantees were released when the 4.625% senior notes were repaid on October 15, 2015.
The Company applies the equity method of accounting to its subsidiaries. For cash management purposes, the Company transfers cash among Parent Company Guarantor, Issuer, Guarantor Subsidiary and all other non-guarantor subsidiaries (the “Non-Guarantor Subsidiaries”) through intercompany financing arrangements, contributions or declaration of dividends between the respective parent and its subsidiaries. The transfer of cash under these activities facilitates the ability of the recipient to make specified third-party payments for principal and interest on the Company’s outstanding debt, common stock dividends and common stock repurchases. The consolidating statements of cash flows for the periods included herein present such intercompany financing activities, contributions and dividends consistent with how such activity would be presented in a stand-alone statement of cash flows. There are no significant restrictions on the ability of the Issuer or the Guarantors to obtain funds from subsidiaries by dividend or loan.
The following consolidating financial information presents the financial condition, results of operations and cash flows of the Parent Company Guarantor, Issuer, Guarantor Subsidiary, and the Non-Guarantor Subsidiaries, together with consolidating adjustments necessary to present Albemarle’s results on a consolidated basis, and should be read in conjunction with the notes to the condensed consolidated financial statements. Each entity in the consolidating financial information follows the same accounting policies as described herein and in our Annual Report on Form 10-K for the year ended December 31, 2014.
Condensed Consolidating Statement of Income
Three Months Ended September 30, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
357,269

 
$

 
$

 
$
734,109

 
$
(186,285
)
 
$
905,093

Cost of goods sold
252,634

 

 

 
526,534

 
(186,285
)
 
592,883

Gross profit
104,635

 

 

 
207,575

 

 
312,210

Selling, general and administrative expenses
40,721

 

 

 
96,894

 

 
137,615

Research and development expenses
12,874

 

 

 
12,421

 

 
25,295

Restructuring and other, net
(61
)
 

 

 
(6,743
)
 

 
(6,804
)
Acquisition and integration related costs
28,479

 

 

 
14,319

 

 
42,798

Intercompany service fee
5,914

 

 

 
(5,914
)
 

 

Operating profit
16,708

 

 

 
96,598

 

 
113,306

Interest and financing expenses
(21,758
)
 
(12,546
)
 

 
2,246

 

 
(32,058
)
Intergroup interest and financing expenses
(8,697
)
 
15,147

 

 
(6,450
)
 

 

Other income (expenses), net
(2,320
)
 
4,376

 

 
(1,590
)
 

 
466

Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments
(16,067
)
 
6,977

 

 
90,804

 

 
81,714

Income tax expense (benefit)
(9,491
)
 
4,020

 

 
22,363

 

 
16,892

Income (loss) from continuing operations before equity in net income of unconsolidated investments
(6,576
)
 
2,957

 

 
68,441

 

 
64,822

Equity in net income of unconsolidated investments (net of tax)
1,315

 

 

 
4,735

 

 
6,050

Net income (loss) from continuing operations
(5,261
)
 
2,957

 

 
73,176

 

 
70,872

Income (loss) from discontinued operations (net of tax)

 

 

 

 

 

Equity in undistributed earnings of subsidiaries
70,653

 
15,254

 
18,211

 
18,211

 
(122,329
)
 

Net income
65,392

 
18,211

 
18,211

 
91,387

 
(122,329
)
 
70,872

Net income attributable to noncontrolling interests

 

 

 
(5,480
)
 

 
(5,480
)
Net income attributable to Albemarle Corporation
$
65,392

 
$
18,211

 
$
18,211

 
$
85,907

 
$
(122,329
)
 
$
65,392



Condensed Consolidating Statement of Comprehensive Income (Loss)
Three Months Ended September 30, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
65,392

 
$
18,211

 
$
18,211

 
$
91,387

 
$
(122,329
)
 
$
70,872

Total other comprehensive loss, net of tax
(70,007
)
 
(51,882
)
 
(51,882
)
 
(118,228
)
 
221,595

 
(70,404
)
Comprehensive income (loss)
(4,615
)
 
(33,671
)
 
(33,671
)
 
(26,841
)
 
99,266

 
468

Comprehensive income attributable to noncontrolling interests

 

 

 
(5,083
)
 

 
(5,083
)
Comprehensive loss attributable to Albemarle Corporation
$
(4,615
)
 
$
(33,671
)
 
$
(33,671
)
 
$
(31,924
)
 
$
99,266

 
$
(4,615
)

Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,109,661

 
$

 
$

 
$
2,153,749

 
$
(542,428
)
 
$
2,720,982

Cost of goods sold
767,626

 

 

 
1,622,121

 
(540,007
)
 
1,849,740

Gross profit
342,035

 

 

 
531,628

 
(2,421
)
 
871,242

Selling, general and administrative expenses
127,591

 
46

 

 
293,455

 

 
421,092

Research and development expenses
39,143

 

 

 
37,980

 

 
77,123

Restructuring and other, net
(61
)
 

 

 
(6,743
)
 

 
(6,804
)
Acquisition and integration related costs
86,648

 

 

 
39,839

 

 
126,487

Intercompany service fee
17,557

 

 

 
(17,557
)
 

 

Operating profit (loss)
71,157

 
(46
)
 

 
184,654

 
(2,421
)
 
253,344

Interest and financing expenses
(70,279
)
 
(36,257
)
 

 
5,550

 

 
(100,986
)
Intergroup interest and financing expenses
(23,143
)
 
40,862

 

 
(17,719
)
 

 

Other income (expenses), net
6,624

 
(26,844
)
 

 
71,184

 

 
50,964

Income (loss) from continuing operations before income taxes and equity in net income of unconsolidated investments
(15,641
)
 
(22,285
)
 

 
243,669

 
(2,421
)
 
203,322

Income tax expense (benefit)
(1,148
)
 
6,992

 

 
43,219

 
(892
)
 
48,171

Income (loss) from continuing operations before equity in net income of unconsolidated investments
(14,493
)
 
(29,277
)
 

 
200,450

 
(1,529
)
 
155,151

Equity in net income of unconsolidated investments (net of tax)
5,072

 

 

 
17,164

 

 
22,236

Net income (loss) from continuing operations
(9,421
)
 
(29,277
)
 

 
217,614

 
(1,529
)
 
177,387

Income (loss) from discontinued operations (net of tax)

 

 

 

 

 

Equity in undistributed earnings of subsidiaries
170,075

 
73,212

 
43,935

 
43,935

 
(331,157
)
 

Net income
160,654

 
43,935

 
43,935

 
261,549

 
(332,686
)
 
177,387

Net income attributable to noncontrolling interests

 

 

 
(16,733
)
 

 
(16,733
)
Net income attributable to Albemarle Corporation
$
160,654

 
$
43,935

 
$
43,935

 
$
244,816

 
$
(332,686
)
 
$
160,654



Condensed Consolidating Statement of Comprehensive Loss
Nine Months Ended September 30, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
160,654

 
$
43,935

 
$
43,935

 
$
261,549

 
$
(332,686
)
 
$
177,387

Total other comprehensive loss, net of tax
(324,000
)
 
(269,219
)
 
(269,220
)
 
(662,793
)
 
1,200,684

 
(324,548
)
Comprehensive loss
(163,346
)
 
(225,284
)
 
(225,285
)
 
(401,244
)
 
867,998

 
(147,161
)
Comprehensive income attributable to noncontrolling interests

 

 

 
(16,185
)
 

 
(16,185
)
Comprehensive loss attributable to Albemarle Corporation
$
(163,346
)
 
$
(225,284
)
 
$
(225,285
)
 
$
(417,429
)
 
$
867,998

 
$
(163,346
)


Condensed Consolidating Statement of Income
Three Months Ended September 30, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
403,072

 
$

 
$

 
$
424,423

 
$
(185,077
)
 
$
642,418

Cost of goods sold
275,187

 

 

 
342,149

 
(180,364
)
 
436,972

Gross profit
127,885

 

 

 
82,274

 
(4,713
)
 
205,446

Selling, general and administrative expenses
42,836

 

 

 
23,176

 

 
66,012

Research and development expenses
13,959

 

 

 
8,448

 

 
22,407

Restructuring and other, net
(2,197
)
 

 

 
2,490

 

 
293

Acquisition and integration related costs
10,261

 

 

 

 

 
10,261

Intercompany service fee
11,664

 

 

 
(11,664
)
 

 

Operating profit
51,362

 

 

 
59,824

 
(4,713
)
 
106,473

Interest and financing expenses
(8,791
)
 

 

 
42

 

 
(8,749
)
Other income (expenses), net
(3,151
)
 

 

 
(3,467
)
 

 
(6,618
)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments
39,420

 

 

 
56,399

 
(4,713
)
 
91,106

Income tax expense
7,636

 

 

 
5,823

 
(1,722
)
 
11,737

Income from continuing operations before equity in net income of unconsolidated investments
31,784

 

 

 
50,576

 
(2,991
)
 
79,369

Equity in net income of unconsolidated investments (net of tax)
997

 

 

 
7,653

 

 
8,650

Net income from continuing operations
32,781

 

 

 
58,229

 
(2,991
)
 
88,019

Loss from discontinued operations (net of tax)
608

 

 

 
(7,287
)
 

 
(6,679
)
Equity in undistributed earnings of subsidiaries
39,405

 

 

 

 
(39,405
)
 

Net income
72,794

 

 

 
50,942

 
(42,396
)
 
81,340

Net income attributable to noncontrolling interests

 

 

 
(8,546
)
 

 
(8,546
)
Net income attributable to Albemarle Corporation
$
72,794

 
$

 
$

 
$
42,396

 
$
(42,396
)
 
$
72,794



Condensed Consolidating Statement of Comprehensive Loss
Three Months Ended September 30, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
72,794

 
$

 
$

 
$
50,942

 
$
(42,396
)
 
$
81,340

Total other comprehensive loss, net of tax
(101,295
)
 

 

 
(100,260
)
 
100,135

 
(101,420
)
Comprehensive loss
(28,501
)
 

 

 
(49,318
)
 
57,739

 
(20,080
)
Comprehensive income attributable to noncontrolling interests

 

 

 
(8,421
)
 

 
(8,421
)
Comprehensive loss attributable to Albemarle Corporation
$
(28,501
)
 
$

 
$

 
$
(57,739
)
 
$
57,739

 
$
(28,501
)
Condensed Consolidating Statement of Income
Nine Months Ended September 30, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net sales
$
1,198,531

 
$

 
$

 
$
1,169,507

 
$
(521,056
)
 
$
1,846,982

Cost of goods sold
804,764

 

 

 
953,726

 
(519,916
)
 
1,238,574

Gross profit
393,767

 

 

 
215,781

 
(1,140
)
 
608,408

Selling, general and administrative expenses
141,411

 

 

 
69,716

 

 
211,127

Research and development expenses
41,772

 

 

 
25,144

 

 
66,916

Restructuring and other, net
8,049

 

 

 
12,576

 

 
20,625

Acquisition and integration related costs
15,104

 

 

 

 

 
15,104

Intercompany service fee
23,672

 

 

 
(23,672
)
 

 

Operating profit
163,759

 

 

 
132,017

 
(1,140
)
 
294,636

Interest and financing expenses
(26,320
)
 

 

 
65

 

 
(26,255
)
Intergroup interest and financing expenses
6,010

 

 

 
(6,010
)
 

 

Other income (expenses), net
(2,161
)
 

 

 
(4,293
)
 

 
(6,454
)
Income from continuing operations before income taxes and equity in net income of unconsolidated investments
141,288

 

 

 
121,779

 
(1,140
)
 
261,927

Income tax expense
40,156

 

 

 
6,960

 
(416
)
 
46,700

Income from continuing operations before equity in net income of unconsolidated investments
101,132

 

 

 
114,819

 
(724
)
 
215,227

Equity in net income of unconsolidated investments (net of tax)
4,926

 

 

 
23,274

 

 
28,200

Net income from continuing operations
106,058

 

 

 
138,093

 
(724
)
 
243,427

Loss from discontinued operations (net of tax)
(20,549
)
 

 

 
(47,924
)
 

 
(68,473
)
Equity in undistributed earnings of subsidiaries
66,315

 

 

 

 
(66,315
)
 

Net income
151,824

 

 

 
90,169

 
(67,039
)
 
174,954

Net income attributable to noncontrolling interests

 

 

 
(23,130
)
 

 
(23,130
)
Net income attributable to Albemarle Corporation
$
151,824

 
$

 
$

 
$
67,039

 
$
(67,039
)
 
$
151,824



Condensed Consolidating Statement of Comprehensive Income (Loss)
Nine Months Ended September 30, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Net income
$
151,824

 
$

 
$

 
$
90,169

 
$
(67,039
)
 
$
174,954

Total other comprehensive loss, net of tax
(117,896
)
 

 

 
(106,319
)
 
105,916

 
(118,299
)
Comprehensive income (loss)
33,928

 

 

 
(16,150
)
 
38,877

 
56,655

Comprehensive income attributable to noncontrolling interests

 

 

 
(22,727
)
 

 
(22,727
)
Comprehensive income (loss) attributable to Albemarle Corporation
$
33,928

 
$

 
$

 
$
(38,877
)
 
$
38,877

 
$
33,928


Condensed Consolidating Balance Sheet
September 30, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
4,416

 
$
1,103

 
$

 
$
228,971

 
$

 
$
234,490

Trade accounts receivable, less allowance for doubtful accounts
92,694

 

 

 
525,607

 

 
618,301

Other accounts receivable
15,031

 
23,915

 

 
37,325

 

 
76,271

Intergroup receivable
191,295

 
12,455

 

 
352,388

 
(556,138
)
 

Inventories
207,445

 

 

 
435,211

 
(13,263
)
 
629,393

Other current assets
51,717

 

 

 
121,821

 
(11,078
)
 
162,460

Total current assets
562,598

 
37,473

 

 
1,701,323

 
(580,479
)
 
1,720,915

Property, plant and equipment, at cost
1,765,817

 

 

 
2,331,104

 

 
4,096,921

Less accumulated depreciation and amortization
1,087,130

 

 

 
408,939

 

 
1,496,069

Net property, plant and equipment
678,687

 

 

 
1,922,165

 

 
2,600,852

Investments
74,429

 
4,891

 

 
374,549

 

 
453,869

Investment in subsidiaries
7,073,096

 
4,783,860

 
6,380,635

 
6,380,635

 
(24,618,226
)
 

Other assets
30,572

 
3,250

 

 
157,527

 

 
191,349

Goodwill
49,212

 

 

 
2,761,874

 

 
2,811,086

Other intangibles, net of amortization
19,265

 

 

 
1,877,728

 

 
1,896,993

Intergroup receivable

 
3,305,771

 
2,227

 
1,847,122

 
(5,155,120
)
 

Total assets
$
8,487,859

 
$
8,135,245

 
$
6,382,862

 
$
17,022,923

 
$
(30,353,825
)
 
$
9,675,064

Liabilities and Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
121,835

 
$

 
$

 
$
249,814

 
$

 
$
371,649

Intergroup payable
365,452

 
102,004

 
82

 
88,600

 
(556,138
)
 

Accrued expenses
189,637

 
137,161

 

 
240,134

 

 
566,932

Current portion of long-term debt
272,994

 

 

 
11,374

 

 
284,368

Dividends payable
32,295

 

 

 

 

 
32,295

Income taxes payable

 
11,076

 

 
68,196

 
(11,968
)
 
67,304

Total current liabilities
982,213

 
250,241

 
82

 
658,118

 
(568,106
)
 
1,322,548

Long-term debt
2,230,720

 
1,287,643

 

 
40,601

 

 
3,558,964

Postretirement benefits
55,401

 

 

 

 

 
55,401

Pension benefits
120,593

 

 

 
330,463

 

 
451,056

Intergroup payable
1,810,546

 
155,701

 
863,757

 
2,325,116

 
(5,155,120
)
 

Other noncurrent liabilities
53,933

 
57,995

 

 
138,809

 

 
250,737

Deferred income taxes
89,964

 
3,031

 

 
668,849

 

 
761,844

Commitments and contingencies


 


 


 


 


 


Equity:
 
 
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
 
 
Common stock
1,122

 

 

 
6,808

 
(6,808
)
 
1,122

Additional paid-in capital
2,056,082

 
6,605,919

 
5,744,307

 
12,159,684

 
(24,509,910
)
 
2,056,082

Accumulated other comprehensive loss
(386,413
)
 
(269,220
)
 
(269,219
)
 
(713,001
)
 
1,251,440

 
(386,413
)
Retained earnings
1,473,698

 
43,935

 
43,935

 
1,277,451

 
(1,365,321
)
 
1,473,698

Total Albemarle Corporation shareholders’ equity
3,144,489

 
6,380,634

 
5,519,023

 
12,730,942

 
(24,630,599
)
 
3,144,489

Noncontrolling interests

 

 

 
130,025

 

 
130,025

Total equity
3,144,489

 
6,380,634

 
5,519,023

 
12,860,967

 
(24,630,599
)
 
3,274,514

Total liabilities and equity
$
8,487,859

 
$
8,135,245

 
$
6,382,862

 
$
17,022,923

 
$
(30,353,825
)
 
$
9,675,064


Condensed Consolidating Balance Sheet
December 31, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Assets
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1,930,802

 
$

 
$

 
$
558,966

 
$

 
$
2,489,768

Trade accounts receivable, less allowance for doubtful accounts
91,849

 

 

 
293,363

 

 
385,212

Other accounts receivable
19,033

 

 

 
30,390

 

 
49,423

Intergroup receivable
74,102

 

 

 
18,097

 
(92,199
)
 

Inventories
201,006

 

 

 
171,543

 
(14,188
)
 
358,361

Other current assets
45,901

 

 

 
25,111

 
(4,926
)
 
66,086

Total current assets
2,362,693

 

 

 
1,097,470

 
(111,313
)
 
3,348,850

Property, plant and equipment, at cost
1,726,690

 

 

 
893,980

 

 
2,620,670

Less accumulated depreciation and amortization
1,047,372

 

 

 
341,430

 

 
1,388,802

Net property, plant and equipment
679,318

 

 

 
552,550

 

 
1,231,868

Investments
73,500

 

 

 
120,542

 

 
194,042

Investment in subsidiaries
1,551,071

 

 

 

 
(1,551,071
)
 

Other assets
35,837

 

 

 
125,119

 

 
160,956

Goodwill
49,212

 

 

 
194,050

 

 
243,262

Other intangibles, net of amortization
20,834

 

 

 
23,291

 

 
44,125

Total assets
$
4,772,465

 
$

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103

Liabilities and Equity
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
$
122,479

 
$

 
$

 
$
109,226

 
$

 
$
231,705

Intergroup payable
18,097

 

 

 
74,102

 
(92,199
)
 

Accrued expenses
84,619

 

 

 
81,555

 

 
166,174

Current portion of long-term debt
692,280

 

 

 
18,816

 

 
711,096

Dividends payable
21,458

 

 

 

 

 
21,458

Income taxes payable
1,396

 

 

 
7,944

 
113

 
9,453

Total current liabilities
940,329

 

 

 
291,643

 
(92,086
)
 
1,139,886

Long-term debt
2,214,755

 

 

 
8,280

 

 
2,223,035

Postretirement benefits
56,424

 

 

 

 

 
56,424

Pension benefits
128,238

 

 

 
42,296

 

 
170,534

Other noncurrent liabilities
51,936

 

 

 
35,769

 

 
87,705

Deferred income taxes
21,318

 

 

 
35,566

 

 
56,884

Commitments and contingencies


 


 


 


 


 


Equity:
 
 
 
 
 
 
 
 
 
 
 
Albemarle Corporation shareholders’ equity:
 
 
 
 
 
 
 
 
 
 
 
Common stock
780

 

 

 
6,808

 
(6,808
)
 
780

Additional paid-in capital
10,447

 

 

 
553,172

 
(553,172
)
 
10,447

Accumulated other comprehensive loss
(62,413
)
 

 

 
(51,073
)
 
51,073

 
(62,413
)
Retained earnings
1,410,651

 

 

 
1,061,391

 
(1,061,391
)
 
1,410,651

Total Albemarle Corporation shareholders’ equity
1,359,465

 

 

 
1,570,298

 
(1,570,298
)
 
1,359,465

Noncontrolling interests

 

 

 
129,170

 

 
129,170

Total equity
1,359,465

 

 

 
1,699,468

 
(1,570,298
)
 
1,488,635

Total liabilities and equity
$
4,772,465

 
$

 
$

 
$
2,113,022

 
$
(1,662,384
)
 
$
5,223,103


Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2015
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
1,930,802

 
$

 
$

 
$
558,966

 
$

 
$
2,489,768

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
369,333

 
(48,949
)
 
82

 
19,839

 
(23,402
)
 
316,903

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Acquisition of Rockwood, net of cash acquired
(3,597,083
)
 
159,409

 

 
1,386,029

 

 
(2,051,645
)
Other acquisitions, net of cash acquired

 

 

 
(48,845
)
 

 
(48,845
)
Capital expenditures
(51,900
)
 

 

 
(112,668
)
 

 
(164,568
)
Decrease in restricted cash

 

 

 
57,550

 

 
57,550

Cash proceeds from divestitures, net

 

 

 
6,133

 

 
6,133

Return of capital

 

 

 
98,000

 

 
98,000

Sales of (investments in) marketable securities, net
1,271

 

 

 
(6
)
 

 
1,265

Repayments from (long-term advances to) joint ventures
2,156

 

 

 

 

 
2,156

Proceeds from intercompany investing related activity

 
1,213,717

 

 
82

 
(1,213,799
)
 

Intercompany investing related payments

 
(1,324,960
)
 

 
(1,341,728
)
 
2,666,688

 

Net cash (used in) provided by investing activities
(3,645,556
)
 
48,166

 

 
44,547

 
1,452,889

 
(2,099,954
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(1,325,104
)
 

 

 
(7,189
)
 

 
(1,332,293
)
Proceeds from borrowings of long-term debt
1,000,000

 

 

 

 

 
1,000,000

Repayments of other borrowings, net
(16,018
)
 

 

 
(836
)
 

 
(16,854
)
Dividends paid to shareholders
(86,770
)
 

 

 

 

 
(86,770
)
Dividends paid to noncontrolling interests

 

 

 
(23,195
)
 

 
(23,195
)
Intercompany dividends paid

 

 

 
(23,402
)
 
23,402

 

Proceeds from exercise of stock options
342

 

 

 

 

 
342

Excess tax benefits realized from stock-based compensation arrangements
59

 

 

 

 

 
59

Withholding taxes paid on stock-based compensation award distributions
(1,218
)
 

 

 

 

 
(1,218
)
Debt financing costs
(4,186
)
 

 

 

 

 
(4,186
)
Other

 

 

 
(3,882
)
 

 
(3,882
)
Proceeds from intercompany financing related activity
1,845,770

 

 

 
820,918

 
(2,666,688
)
 

Intercompany financing related payments
(62,039
)
 

 
(82
)
 
(1,151,678
)
 
1,213,799

 

Net cash provided by (used in) financing activities
1,350,836

 

 
(82
)
 
(389,264
)
 
(1,429,487
)
 
(467,997
)
Net effect of foreign exchange on cash and cash equivalents
(999
)
 
1,886

 

 
(5,117
)
 

 
(4,230
)
(Decrease) increase in cash and cash equivalents
(1,926,386
)
 
1,103

 

 
(329,995
)
 

 
(2,255,278
)
Cash and cash equivalents at end of period
$
4,416

 
$
1,103

 
$

 
$
228,971

 
$

 
$
234,490


Condensed Consolidating Statement Of Cash Flows
Nine Months Ended September 30, 2014
(In Thousands)
Parent Company Guarantor
 
Issuer
 
Guarantor Subsidiary
 
Non-Guarantor Subsidiaries
 
Consolidating Adjustments
 
Consolidated Total
Cash and cash equivalents at beginning of year
$
88,476

 
$

 
$

 
$
388,763

 
$

 
$
477,239

Cash flows from operating activities:
 
 
 
 
 
 
 
 
 
 
 
Net cash provided by operating activities
203,834

 

 

 
232,718

 
(6,010
)
 
430,542

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures
(57,124
)
 

 

 
(19,558
)
 

 
(76,682
)
Cash proceeds from divestitures, net
97,523

 

 

 
7,195

 

 
104,718

Sales of (investments in) marketable securities, net
962

 

 

 
(19
)
 

 
943

Repayments from (long-term advances to) joint ventures

 

 

 
(7,499
)
 

 
(7,499
)
Net cash provided by (used in) investing activities
41,361

 

 

 
(19,881
)
 

 
21,480

Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Repayments of long-term debt
(108
)
 

 

 
(2,915
)
 

 
(3,023
)
Repayments of other borrowings, net
(7,124
)
 

 

 
(16,430
)
 

 
(23,554
)
Dividends paid to shareholders
(62,827
)
 

 

 

 

 
(62,827
)
Dividends paid to noncontrolling interests

 

 

 
(7,612
)
 

 
(7,612
)
Intercompany dividends paid

 

 

 
(6,010
)
 
6,010

 

Repurchases of common stock
(150,000
)
 

 

 

 

 
(150,000
)
Proceeds from exercise of stock options
2,713

 

 

 

 

 
2,713

Excess tax benefits realized from stock-based compensation arrangements
836

 

 

 

 

 
836

Withholding taxes paid on stock-based compensation award distributions
(3,208
)
 

 

 

 

 
(3,208
)
Debt financing costs
(3,074
)
 

 

 

 

 
(3,074
)
Net cash used in financing activities
(222,792
)
 

 

 
(32,967
)
 
6,010

 
(249,749
)
Net effect of foreign exchange on cash and cash equivalents

 

 

 
(26,392
)
 

 
(26,392
)
Increase in cash and cash equivalents
22,403

 

 

 
153,478

 

 
175,881

Cash and cash equivalents at end of period
$
110,879

 
$

 
$

 
$
542,241

 
$

 
$
653,120